Optic Pathway Glioma Opg clinical trials

Explore recruiting optic pathway glioma opg clinical trials.

Also recruiting in Europe

Optic Pathway Glioma Opg trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and Efficacy of multiple doses of the PAINLESS Nerve Growth Factor CHF6467 in paediatric subjects with Optic Pathway Glioma (OPG). A randomized clinical trial (RCT)

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Optic Pathway Glioma Opg trials by city

Optic Pathway Glioma Opg in Toronto Optic Pathway Glioma Opg in Vancouver Optic Pathway Glioma Opg in Montreal Optic Pathway Glioma Opg in Calgary Optic Pathway Glioma Opg in Edmonton Optic Pathway Glioma Opg in Ottawa Optic Pathway Glioma Opg in Winnipeg Optic Pathway Glioma Opg in Quebec City Optic Pathway Glioma Opg in Hamilton Optic Pathway Glioma Opg in Kitchener Optic Pathway Glioma Opg in London Optic Pathway Glioma Opg in Halifax Optic Pathway Glioma Opg in New York Optic Pathway Glioma Opg in Los Angeles Optic Pathway Glioma Opg in Chicago Optic Pathway Glioma Opg in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease